Investor profile
Swisscanto Invest has backed 7 European tech companies across 9 funding rounds between 2019 and 2023, joining rounds totalling €212M. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Also recorded as: SwissCanto
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Beekeeper | Switzerland | 2 | €91M |
| Memo Therapeutics | Switzerland | 2 | €61M |
| Medimaps Group | Switzerland | 1 | €18M |
| Swissto12 | Switzerland | 1 | €17M |
| Fotokite | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Beekeeper | Series C | €50M | 2022-11 |
| Beekeeper | Series B | €41M | 2019-10 |
| Memo Therapeutics | Series B | €35M | 2022-02 |
| Memo Therapeutics |
| 1 |
| €13M |
| Tado | Germany | 1 | €12M |
| Sulzer Schmid | Switzerland | 1 | €0 |
| Series C |
| €26M |
| 2023-11 |
| Medimaps Group | Other | €18M | 2021-12 |
| Swissto12 | Series B | €17M | 2019-10 |
| Fotokite | Series B | €13M | 2022-01 |
| Tado | Other | €12M | 2023-04 |
